These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 23625613)

  • 1. Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis.
    Nakagawa H
    Endocr Relat Cancer; 2013 Aug; 20(4):R171-81. PubMed ID: 23625613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.
    Chung S; Nakagawa H; Uemura M; Piao L; Ashikawa K; Hosono N; Takata R; Akamatsu S; Kawaguchi T; Morizono T; Tsunoda T; Daigo Y; Matsuda K; Kamatani N; Nakamura Y; Kubo M
    Cancer Sci; 2011 Jan; 102(1):245-52. PubMed ID: 20874843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer genomics, biology, and risk assessment through genome-wide association studies.
    Nakagawa H; Akamatsu S; Takata R; Takahashi A; Kubo M; Nakamura Y
    Cancer Sci; 2012 Apr; 103(4):607-13. PubMed ID: 22181854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genome-wide association study(GWAS) and genetic risk of prostate cancer].
    Nakagawa H; Akamatsu S; Takata R
    Nihon Rinsho; 2016 Jan; 74(1):34-9. PubMed ID: 26793876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostate cancer genome: perspectives and potential.
    Barbieri CE; Tomlins SA
    Urol Oncol; 2014 Jan; 32(1):53.e15-22. PubMed ID: 24239470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.
    Barbieri CE; Demichelis F; Rubin MA
    Histopathology; 2012 Jan; 60(1):187-98. PubMed ID: 22212086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer: germline prediction for a commonly variable malignancy.
    Bambury RM; Gallagher DJ
    BJU Int; 2012 Dec; 110(11 Pt C):E809-18. PubMed ID: 22974436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing the transcriptional network of androgen receptor in prostate cancer.
    Chng KR; Cheung E
    Cancer Lett; 2013 Nov; 340(2):254-60. PubMed ID: 23196061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IRX4 at 5p15 suppresses prostate cancer growth through the interaction with vitamin D receptor, conferring prostate cancer susceptibility.
    Nguyen HH; Takata R; Akamatsu S; Shigemizu D; Tsunoda T; Furihata M; Takahashi A; Kubo M; Kamatani N; Ogawa O; Fujioka T; Nakamura Y; Nakagawa H
    Hum Mol Genet; 2012 May; 21(9):2076-85. PubMed ID: 22323358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resequencing rice genomes: an emerging new era of rice genomics.
    Huang X; Lu T; Han B
    Trends Genet; 2013 Apr; 29(4):225-32. PubMed ID: 23295340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reprint of: The prostate cancer genome: Perspectives and potential.
    Barbieri CE; Tomlins SA
    Urol Oncol; 2015 Feb; 33(2):95-102. PubMed ID: 25726356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary/familial versus sporadic prostate cancer: few indisputable genetic differences and many similar clinicopathological features.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2010 Jan; 14(1):31-41. PubMed ID: 20184087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic analysis in prostate cancer].
    Kobayashi T; Ogawa O
    Nihon Rinsho; 2014 Dec; 72(12):2217-23. PubMed ID: 25518361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate Cancer Genomics: Recent Advances and the Prevailing Underrepresentation from Racial and Ethnic Minorities.
    Tan SH; Petrovics G; Srivastava S
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29690565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of genome-wide and replication association studies on prostate cancer.
    Liu H; Wang B; Han C
    Prostate; 2011 Feb; 71(2):209-24. PubMed ID: 20690139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating germline and somatic variation information using genomic data for the discovery of biomarkers in prostate cancer.
    Mamidi TKK; Wu J; Hicks C
    BMC Cancer; 2019 Mar; 19(1):229. PubMed ID: 30871495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care.
    Roukos DH
    Expert Rev Mol Diagn; 2010 Jan; 10(1):33-48. PubMed ID: 20014921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer and the genomic revolution: Advances using microarray analyses.
    Calvo A; Gonzalez-Moreno O; Yoon CY; Huh JI; Desai K; Nguyen QT; Green JE
    Mutat Res; 2005 Aug; 576(1-2):66-79. PubMed ID: 15950992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prostate cancer risk locus at 10q11 is associated with DNA repair capacity.
    Rinckleb AE; Surowy HM; Luedeke M; Varga D; Schrader M; Hoegel J; Vogel W; Maier C
    DNA Repair (Amst); 2012 Aug; 11(8):693-701. PubMed ID: 22677538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression correlation analysis predicts involvement of high- and low-confidence risk genes in different stages of prostate carcinogenesis.
    Yano K
    Prostate; 2010 Dec; 70(16):1746-59. PubMed ID: 20564324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.